The action of batulinum toxin at the neuromuscular junction
- PMID: 6115105
The action of batulinum toxin at the neuromuscular junction
Abstract
Botulism results from the action of a protein neurotoxin (mol. wt. congruent to 150,000) produced by the bacterium Clostridium botulinum, of which there are eight known strains. Botulinum neurotoxin is the most potent biological toxin known, having a median lethal dose of 5--50 ng/kg body weight. The primary site of action of botulinum toxin is the cholinergic nerve terminal, where it blocks the release of the neurotransmitter acetylcholine. Death usually results from respiratory failure. Nonlethal doses of botulinum toxin can induce sprouting of the nerve terminal and have significant postsynaptic effects, including muscle atrophy and alterations in the membrane electrical properties of the muscle fiber. There is no universally available treatment for botulinum intoxication. However, immunotherapeutic and chemotherapeutic procedures are not being developed and will be discussed.
Similar articles
-
[Mode of action and effects of botulinum neurotoxin A].Ann Otolaryngol Chir Cervicofac. 1996;113(2):73-8. Ann Otolaryngol Chir Cervicofac. 1996. PMID: 8999747 French.
-
[Clostridium botulinum and botulinum neurotoxin].Brain Nerve. 2011 Jul;63(7):755-61. Brain Nerve. 2011. PMID: 21747146 Review. Japanese.
-
A preclinical evaluation of aminopyridines as putative therapeutic agents in the treatment of botulism.Infect Immun. 1986 Jun;52(3):858-62. doi: 10.1128/iai.52.3.858-862.1986. Infect Immun. 1986. PMID: 3011675 Free PMC article.
-
In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches.J Pharmacol Exp Ther. 1997 Mar;280(3):1489-98. J Pharmacol Exp Ther. 1997. PMID: 9067339
-
[Molecular mechanism of action of tetanus toxin and botulinum neurotoxins].Pathol Biol (Paris). 1994 Feb;42(2):173-82. Pathol Biol (Paris). 1994. PMID: 7916455 Review. French.
Cited by
-
Dependence of Clostridium botulinum gas and protease production on culture conditions.Appl Environ Microbiol. 1983 Feb;45(2):571-5. doi: 10.1128/aem.45.2.571-575.1983. Appl Environ Microbiol. 1983. PMID: 6338828 Free PMC article.
-
Emerging Opportunities in Human Pluripotent Stem-Cells Based Assays to Explore the Diversity of Botulinum Neurotoxins as Future Therapeutics.Int J Mol Sci. 2021 Jul 14;22(14):7524. doi: 10.3390/ijms22147524. Int J Mol Sci. 2021. PMID: 34299143 Free PMC article. Review.
-
Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospasm.J Neurol Neurosurg Psychiatry. 1991 Apr;54(4):310-3. doi: 10.1136/jnnp.54.4.310. J Neurol Neurosurg Psychiatry. 1991. PMID: 1647444 Free PMC article.
-
A double blind trial of botulinum toxin "A" in torticollis, with one year follow up.J Neurol Neurosurg Psychiatry. 1991 Sep;54(9):813-6. doi: 10.1136/jnnp.54.9.813. J Neurol Neurosurg Psychiatry. 1991. PMID: 1955900 Free PMC article. Clinical Trial.
-
Dithiobiuret neurotoxicity: an ultrastructural investigation of the lesion in preterminal axons and motor endplates in the rat lumbrical muscle.Acta Neuropathol. 1989;78(1):72-85. doi: 10.1007/BF00687405. Acta Neuropathol. 1989. PMID: 2500004
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical